275 related articles for article (PubMed ID: 30158057)
1. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ
Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057
[TBL] [Abstract][Full Text] [Related]
2. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
[TBL] [Abstract][Full Text] [Related]
3. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
[TBL] [Abstract][Full Text] [Related]
4. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
[TBL] [Abstract][Full Text] [Related]
6. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
[TBL] [Abstract][Full Text] [Related]
7. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
[TBL] [Abstract][Full Text] [Related]
8. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
[TBL] [Abstract][Full Text] [Related]
9. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
[TBL] [Abstract][Full Text] [Related]
10. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
[TBL] [Abstract][Full Text] [Related]
11. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
13. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
[TBL] [Abstract][Full Text] [Related]
14. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ;
Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600
[TBL] [Abstract][Full Text] [Related]
15. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
[TBL] [Abstract][Full Text] [Related]
16. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes of Exercise TraiNing) by sex.
Piña IL; Bittner V; Clare RM; Swank A; Kao A; Safford R; Nigam A; Barnard D; Walsh MN; Ellis SJ; Keteyian SJ;
JACC Heart Fail; 2014 Apr; 2(2):180-6. PubMed ID: 24720927
[TBL] [Abstract][Full Text] [Related]
18. Addition of Supervised Exercise Training to a Post-Hospital Disease Management Program for Patients Recently Hospitalized With Acute Heart Failure: The EJECTION-HF Randomized Phase 4 Trial.
Mudge AM; Denaro CP; Scott AC; Meyers D; Adsett JA; Mullins RW; Suna JM; Atherton JJ; Marwick TH; Scuffham P; O'Rourke P
JACC Heart Fail; 2018 Feb; 6(2):143-152. PubMed ID: 29413370
[TBL] [Abstract][Full Text] [Related]
19. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
[TBL] [Abstract][Full Text] [Related]
20. Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.
Pandey A; Segar MW; Singh S; Reeves GR; O'Connor C; Piña I; Whellan D; Kraus WE; Mentz RJ; Kitzman DW
Circulation; 2022 Jul; 146(2):80-90. PubMed ID: 35616018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
